NEWLINK GENETICS CORP (40) | Uncategorized (12)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 11, 2022)
-
Form of Indemnity Agreement by and between the Registrant and its directors and officers
(Filed With SEC on March 11, 2022)
-
Description of Securities
(Filed With SEC on March 9, 2021)
-
Form of Indemnity Agreement by and between the Registrant and its directors and officers
(Filed With SEC on March 9, 2021)
-
Controlled Equity Offering
(Filed With SEC on December 30, 2020)
-
Amendment No. 1 as of August 12, 2020 to Lumos Merck Agreement with Merck
(Filed With SEC on August 14, 2020)
-
PRV Transfer Agreement, dated as of July 27, 2020, by and between the Registrant and Merck, Sharp & Dohme Corp
(Filed With SEC on August 14, 2020)
-
Description of Securities
(Filed With SEC on March 3, 2020)
-
Form of Support Agreement, by and between NewLink Genetics Corporation and its directors and officers and by and between NewLink Genetics Corporation and Stine Seed Farm, Inc
(Filed With SEC on September 30, 2019)
-
Form of Lock-Up Agreement
(Filed With SEC on September 30, 2019)
-
Amendment to the
(Filed With SEC on March 5, 2019)
-
2019 Equity Awards
(Filed With SEC on March 5, 2019)
